Nexalin Technology's DIFS Approach Shows Promise in Reducing Self-Injury and Depression in Adolescents
Nexalin Technology, Inc. has announced significant findings from a study published in BMC Psychiatry, highlighting the effectiveness of its Deep Intracranial Frequency Stimulation (DIFS) technology. The study focused on six female adolescents with non-suicidal self-injury (NSSI) and reported statistically significant reductions in self-injury behaviors and depressive symptoms following 21 days of 77.5 Hz, 15 mA stimulation. The research also noted changes in brain-network activity and connectivity, providing neurophysiological evidence supporting the non-invasive, high-power DIFS technology. This study adds to Nexalin's growing body of research across various mental health conditions, including insomnia, depression, traumatic brain injury, PTSD, Alzheimer's disease, and ADHD.